Apollo Hospitals Enterprise Limited

NSE:APOLLOHOSP.NS

7030.25 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 190,592166,124.5145,362104,680111,71595,939.2782,233.272,549.0660,855.8851,784.5343,842.2137,687.0531,475.2526,053.520,264.65116,142.05212,147.7189,494.5397,695.8976,607.466
Cost of Revenue 129,86285,742.375,73556,84254,98946,608.6440,326.6135,954.0430,557.7225,811.9821,501.2918,558.3315,595.5213,886.4210,725.9868,728.0076,529.95,098.1174,088.4083,327.567
Gross Profit 60,73080,382.269,62747,83856,72649,330.6341,906.5936,595.0230,298.1625,972.5522,340.9219,128.7215,879.7312,167.089,538.6667,414.0465,617.8184,396.4213,607.4893,279.899
Gross Profit Ratio 0.3190.4840.4790.4570.5080.5140.510.5040.4980.5020.510.5080.5050.4670.4710.4590.4620.4630.4690.496
Reseach & Development Expenses 23421111000000000000000000
General & Administrative Expenses 37,11314,92912,1917,1838,0497,385.36,098.821,346.06939.52643.48511.67500.242,442.543,827.52,342.181,732.7991,246.3060115.37195.505
Selling & Marketing Expenses 6,5806,3973,6481,9982,2711,838.841,742.751,965.681,167.1932.11,065.04832.69862.210378.551427.434309.491099.33784.25
SG&A 43,69321,32615,8399,18110,3209,224.147,841.573,311.742,106.621,575.581,576.711,332.933,304.753,827.52,720.7322,160.2331,555.7980214.707179.754
Other Expenses 1,063903.416118511089.3799.128,955.3117.5513.9617.73301.74-24.993,308.64,213.7363,430.4142,452.3563,034.9982,437.7522,225.03
Operating Expenses 43,69366,038.553,74341,95147,01542,159.0537,372.7232,218.0924,692.3220,445.4517,081.3914,299.7411,124.757,136.16,934.4685,590.6474,008.1533,034.9982,652.462,404.784
Operating Income 17,03714,49215,8845,6729,7136,7424,533.874,376.935,605.845,527.15,259.534,828.984,754.985,030.982,604.1981,823.3981,609.6641,361.423955.029875.115
Operating Income Ratio 0.0890.0870.1090.0540.0870.070.0550.060.0920.1070.120.1280.1510.1930.1290.1130.1330.1430.1240.132
Total Other Income Expenses Net -3,412-3,487-30-3,457-3,143-3,007-2,819.25-2,156.16-1,442.16-972.97-1,192.45-838.2-1,495.25-2,417.8-627.759-479.681-419.949-137.151-281.668-347.482
Income Before Tax 13,62511,007.715,7812,2076,6003,735.411,714.622,220.774,163.684,554.134,067.083,990.783,259.732,613.181,976.4391,343.7171,189.7151,224.272673.361527.633
Income Before Tax Ratio 0.0710.0660.1090.0210.0590.0390.0210.0310.0680.0880.0930.1060.1040.10.0980.0830.0980.1290.0870.08
Income Tax Expense 4,4552,5624,7708472,2521,733.731,119.05909.611,002.181,300.021,017.621,050.371,149.6872.95676.145489.938374.118325.578238.398203.651
Net Income 8,9868,19110,5561,5044,5492,360.461,174.182,209.913,234.873,305.513,063.12,956.992,122.471,755.461,336.593909.697854.452898.695481.368356.307
Net Income Ratio 0.0470.0490.0730.0140.0410.0250.0140.030.0530.0640.070.0780.0670.0670.0660.0560.070.0950.0630.054
EPS 62.556.9773.4210.7432.6916.978.4415.8816.9924.4322.7722.0816.8314.8411.158.67.059.365.414.73
EPS Diluted 62.556.9773.4210.7432.6916.978.4415.8816.9924.4322.7721.8816.314.3711.18.36.779.215.34.73
EBITDA 23,90720,96821,92711,33015,44710,933.668,1567,745.168,123.287,459.386,780.916,305.155,421.494,369.233,355.8262,455.572,094.8621,656.9041,333.3691,186.491
EBITDA Ratio 0.1250.1260.1510.1080.1380.1140.0990.1070.1330.1440.1550.1670.1720.1680.1660.1520.1720.1750.1730.18